Complement Component C3aR Antibody (HC3aRZ8) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-14618F
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Immunohistochemistry-Frozen
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Monoclonal Mouse IgG2B Clone # HC3aRZ8
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Human Complement Component C3aR transfectants
Epitope
The mouse monoclonal antibody HC3aRZ8 recognizes an extracellular epitope of Complement Component C3aR.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for Complement Component C3aR Antibody (HC3aRZ8) [FITC]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Frozen
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Complement Component C3aR
Long Name
Complement Component C3a Receptor
Alternate Names
AZ3B, C3AR, C3AR1, C3R1, Complement Component C3a R
Gene Symbol
C3AR1
Additional Complement Component C3aR Products
Product Documents for Complement Component C3aR Antibody (HC3aRZ8) [FITC]
Product Specific Notices for Complement Component C3aR Antibody (HC3aRZ8) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...